Paper10074902
Analysis of the degradation function of Mdm2.
Kubbutat MH and 3 others. Cell Growth Differ, 1999. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. Analysis of the degradation function of Mdm2. Papers, record 10074902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10074902
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carrier Proteins | Major topic |
| Cell Cycle Proteins | Major topic |
| DNA-Binding Proteins | Major topic |
| Nuclear Proteins | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Animals | |
| Blotting, Western | |
| Cell Line | |
| E2F Transcription Factors | |
| Green Fluorescent Proteins | |
| Humans | |
| Luminescent Proteins | |
| Mice | |
| Mutagenesis | |
| Point Mutation | |
| Precipitin Tests | |
| Proto-Oncogene Proteins c-mdm2 | |
| Retinoblastoma Protein | |
| Retinoblastoma-Binding Protein 1 | |
| Transcription Factor DP1 | |
| Transcription Factors | |
| Transfection |
Source PubMed
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41660279 | Ribosome biogenesis rate, a parameter of sensitivity to chemotherapeutic drugs inhibiting rRNA synthesis. | Oncol Rev | 2025 | https://conductscience.org/library/papers/41660279 | PubMed |
| 36865087 | The SWIB/MDM2 motif of UBE4B activates the p53 pathway. | Mol Ther Nucleic Acids | 2023 | https://conductscience.org/library/papers/36865087 | PubMed |
| 35663101 | Novel Therapies in Myeloproliferative Neoplasms: Beyond JAK Inhibitor Monotherapy. | J Immunother Precis Oncol | 2021 | https://conductscience.org/library/papers/35663101 | PubMed |
| 34626566 | Proteome-wide mapping of short-lived proteins in human cells. | Mol Cell | 2021 | https://conductscience.org/library/papers/34626566 | PubMed |
| 34051140 | Peptide-tiling screens of cancer drivers reveal oncogenic protein domains and associated peptide inhibitors. | Cell Syst | 2021 | https://conductscience.org/library/papers/34051140 | PubMed |
| 30879903 | MDM2 Integrates Cellular Respiration and Apoptotic Signaling through NDUFS1 and the Mitochondrial Network. | Mol Cell | 2019 | https://conductscience.org/library/papers/30879903 | PubMed |
| 30252118 | A single synonymous mutation determines the phosphorylation and stability of the nascent protein. | J Mol Cell Biol | 2019 | https://conductscience.org/library/papers/30252118 | PubMed |
| 28553961 | Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity. | Nat Struct Mol Biol | 2017 | https://conductscience.org/library/papers/28553961 | PubMed |
| 28233861 | Ubiquitin-specific peptidase 48 regulates Mdm2 protein levels independent of its deubiquitinase activity. | Sci Rep | 2017 | https://conductscience.org/library/papers/28233861 | PubMed |
| 27041565 | MDM2 oligomers: antagonizers of the guardian of the genome. | Oncogene | 2016 | https://conductscience.org/library/papers/27041565 | PubMed |
| 26882543 | NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2. | EMBO Rep | 2016 | https://conductscience.org/library/papers/26882543 | PubMed |
| 26416355 | Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells. | Oncotarget | 2015 | https://conductscience.org/library/papers/26416355 | PubMed |
| 25417702 | Functional interplay between MDM2, p63/p73 and mutant p53. | Oncogene | 2015 | https://conductscience.org/library/papers/25417702 | PubMed |
| 24972565 | Pro-angiogenic effects of MDM2 through HIF-1α and NF-κB mediated mechanisms in LNCaP prostate cancer cells. | Mol Biol Rep | 2014 | https://conductscience.org/library/papers/24972565 | PubMed |
| 24567357 | Senescence-inducing stress promotes proteolysis of phosphoglycerate mutase via ubiquitin ligase Mdm2. | J Cell Biol | 2014 | https://conductscience.org/library/papers/24567357 | PubMed |
| 21900752 | MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity. | Cell Cycle | 2011 | https://conductscience.org/library/papers/21900752 | PubMed |
| 21852383 | ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer. | Cancer Res | 2011 | https://conductscience.org/library/papers/21852383 | PubMed |
| 21253554 | Liposarcoma: molecular genetics and therapeutics. | Sarcoma | 2011 | https://conductscience.org/library/papers/21253554 | PubMed |
| 21169420 | MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells. | J Mol Endocrinol | 2011 | https://conductscience.org/library/papers/21169420 | PubMed |
| 21132010 | GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest. | Oncogene | 2011 | https://conductscience.org/library/papers/21132010 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ARID4A | 5926 | PubTator's text mining | https://conductscience.org/library/genes/5926 | NCBI Gene |
| CDKN1A | 1026 | PubTator's text mining | https://conductscience.org/library/genes/1026 | NCBI Gene |
| MDM2 | 4193 | PubTator's text mining | https://conductscience.org/library/genes/4193 | NCBI Gene |
| TFDP1 | 7027 | PubTator's text mining | https://conductscience.org/library/genes/7027 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10074902
GET https://conductscience.org/api/papers/v1/10074902/cited_by?page=2